BNTX BioNTech SE-ADR
Performance
-0.59% Past Week
Market Cap
31.4B
Day’s Range
52W Range
Volume (3M)
682.2K
Price-Earnings Ratio
2.77
Revenue
20.36B
BioNTech SE-ADR Latest News
About BioNTech SE-ADR
BioNTech SE is a German healthcare company based in Mainz, launched in 2008. It works globally, creating and selling immunotherapies. The company trades on the NASDAQ GS under the stock ticker BNTX. For more BNTX stock information, all you need to do is to track this ticker today.
Show More3K
Employees
Mainz, Rheinland-Pfalz, US
HQ
2008
Founded
Ugur Sahin, MD
CEO
Upcoming Earnings
27
MAR
REPORTS
BioNTech SE-ADR Q4 2022 earnings report is expected to be released before market open
Consensus
Moderate Buy
Price Target
180.00
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
49
Medium
Industry
Avg. 45
45
Environment
51
Social
50
Governance
People Also Bought
- BAYN.DE Bayer AG -1.75%
- BIIB Biogen Inc 1.51%
- MRNA Moderna Inc 0.84%
- NVAX Novavax Inc -0.35%
- CVAC CureVac NV 0.46%
129.09